AI-generated summary
The authors reviewed published literature on photobiomodulation, a non-invasive light therapy, as applied to diabetic complications such as kidney disease, neuropathy, retinopathy and wounds. They report that red and near-infrared wavelengths are commonly used across complications, while blue light has mainly been explored for diabetic wounds. They note that treatment parameters vary widely and that few clinical trials exist for most complications.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract notes that treatment parameters are inconsistent and that minimal clinical trials exist for most diabetic complications.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on discovmed.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Near-infrared, Neuropathy, Wound healing, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.